CoChat

Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial

Open access
for the Israel Heart Failure Disease Management Study (IHF-DMS) investigators, Kalter-Leibovici, Ofra, Freimark, Dov, Freedman, Laurence S., Kaufman, Galit, Ziv, Arnona, Murad, Havi, Benderly, Michal, Silverman, Barbara G., Friedman, Nurit, Cukierman-Yaffe, Tali, Asher, Elad, Grupper, Avishay, Goldman, Dorit, Amitai, Miriam, Matetzky, Shlomi, Shani, Mordechai, Silber, Haim · 2017 · BMC Medicine
Cited by 70

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The efficacy of disease management programs in improving the outcome of heart failure patients remains uncertain and may vary across health systems. This study explores whether a countrywide disease management program is superior to usual care in reducing adverse health outcomes and improving well-being among community-dwelling adult patients with moderate-to-severe chronic heart failure who have universal access to advanced health-care services and technologies. METHODS: In this multicenter open-label trial, 1,360 patients recruited after hospitalization for heart failure exacerbation (38%) or from the community (62%) were randomly assigned to either disease management or usual care. Disease management, delivered by multi-disciplinary teams, included coordination of care, patient education, monitoring disease symptoms and patient adherence to medication regimen, titration of drug therapy, and home tele-monitoring of body weight, blood pressure and heart rate. Patients assigned to usual care were treated by primary care practitioners and consultant cardiologists. The primary composite endpoint was the time elapsed till first hospital admission for heart failure exacerbation or death from any cause. Secondary endpoints included the number of all hospital admissions, health-related quality of life and depression during follow-up. Intention-to-treat comparisons between treatments were adjusted for baseline patient data and study center. RESULTS: During the follow-up, 388 (56.9%) patients assigned to disease management and 387 (57.1%) assigned to usual care had a primary endpoint event. The median (range) time elapsed until the primary endpoint event or end of study was 2.0 (0-5.0) years among patients assigned to disease management, and 1.8 (0-5.0) years among patients assigned to usual care (adjusted hazard ratio, 0.908; 95% confidence interval, 0.788 to 1.047). Hospital admissions were mostly (70%) unrelated to heart failure. Patients assigned to disease management had a better health-related quality of life and a lower depression score during follow-up. CONCLUSIONS: This comprehensive disease management intervention was not superior to usual care with respect to the primary composite endpoint, but it improved health-related quality of life and depression. A disease-centered approach may not suffice to make a significant impact on hospital admissions and mortality in patients with chronic heart failure who have universal access to health care. CLINICAL TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT00533013 . Trial registration date: 9 August 2007. Initial protocol release date: 20 September 2007.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12916-017-0855-z

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 70

Metadata

Authors
for the Israel Heart Failure Disease Management Study (IHF-DMS) investigators, Kalter-Leibovici, O., Freimark, D., Freedman, L. S., Kaufman, G., Ziv, A., Murad, H., Benderly, M., Silverman, B. G., Friedman, N., Cukierman-Yaffe, T., Asher, E., Grupper, A., Goldman, D., Amitai, M., Matetzky, S., Shani, M., & Silber, H.
Venue
BMC Medicine
Published
2017-05-01
Volume
15
Issue
1
Pages
90-90
ISSN
1741-7015 (ISSN-L)
OpenAlex
W2609369429
Cited by
70
References
6
FWCI
3.44
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12916-017-0855-z
The paper
for the Israel Heart Failure Disease Management Study (IHF-DMS) investigators, Kalter-Leibovici, O., Freimark, D., Freedman, L. S., Kaufman, G., Ziv, A., Murad, H., Benderly, M., Silverman, B. G., Friedman, N., Cukierman-Yaffe, T., Asher, E., Grupper, A., Goldman, D., Amitai, M., Matetzky, S., Shani, M., & Silber, H. (2017). Disease management in the treatment of patients with chronic heart failure who have universal access to health care: a randomized controlled trial. BMC Medicine. https://doi.org/10.1186/s12916-017-0855-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.